Suchergebnisse - "Wang, Mengzhao"

PubPharm (304)

1

Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors : Final Results of CheckMate 722

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Mok, T. | Nakagawa, K. | Park, K. | +20

2

Hippo pathway in non-small cell lung cancer : mechanisms, potential targets, and biomarkers

enthalten in: Cancer gene therapy | 2024

von Liang, H. | Xu, Y. | Zhao, J. | +2

3

Enhancement of sweetpotato tolerance to chromium stress through melatonin and glutathione : Insights into photosynthetic efficiency, oxidative defense, and growth parameters

enthalten in: Plant physiology and biochemistry : PPB | 2024

von Kumar, S. | Wang, S. | Wang, M. | +5

4

Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6) : single-arm, open-label, multicentre, phase 2 trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Wang, M. | Fan, Y. | Sun, M. | +37

5

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302) : a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Zhong, H. | Sun, S. | Chen, J. | +41

6

Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness : a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial

enthalten in: Trials | 2024

von Tian, X. | Xu, Y. | Wang, L. | +13

7

Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial

enthalten in: Trials | 2024

von Tian, X. | Xu, Y. | Wang, L. | +13

8

Alleviating sweetpotato salt tolerance through exogenous glutathione and melatonin : A profound mechanism for active oxygen detoxification and preservation of photosynthetic organs

enthalten in: Chemosphere | 2024

von Kumar, S. | Liu, Y. | Wang, M. | +5

9

Author Correction : Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC

enthalten in: Nature cancer | 2024

von Zhou, C. | Wang, Z. | Sun, M. | +31

ErratumFor: Nat Cancer. 2023 Jun;4(6):860-871. - PMID 37322367

10

The outcomes of different regimens depend on the molecular subtypes of pulmonary large-cell neuroendocrine carcinoma : A retrospective study in China

enthalten in: Cancer medicine | 2024

von Wang, Z. | Wu, Y. | Lu, T. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]